Drug recall · October 27, 2021
AirDuo Digihaler 232/14 recall
Why: Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-136-06
- Lots / codes
AFR18A
- Quantity
- 5,500 inhalers
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- USA Nationwide
- Initiated
- September 22, 2021 · Voluntary: Firm initiated
- Classified
- October 21, 2021
- Reported
- October 27, 2021
- Ended
- February 16, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluticasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.